Compounded
Semaglutide
Any prescribed dose up to 2.5 mg/week
Prescription & clinician review included
Shipping included
$948 due today
Back to All Reviews
Investigation Report
Aspire Health Tirzepatide Review
Aspire Health, aspirehealth.care
Also spelled as Aspire Health, aspirehealth.care — Same brand, same great service!
Our investigation of Compounded Tirzepatide from Aspire Health
Caution Advised
Multiple red flags identified
6/10
Caution AdvisedRank#130 of 226
Visit Aspire HealthPrescription treatment requires clinician review
Caution Advised
Not published — obtain the consultation fee, medication price and decline policy in writing before paying. Cherry financing available
100+
Hours Researched
6
Verified Pros
7
Issues Found
6
Final Score
These are Med Consumer Watch products, not products from Aspire Health, the brand being reviewed on this page.
Med Consumer Watch GLP-1 plans
GLP-1 weight loss.
A brand on your side.
Med Consumer Watch exists to help consumers make informed choices. Our brand brings that mission to GLP-1 care: clear plan prices, clinician review and support included, so you can compare your options and get started with confidence.
Why choose Med Consumer Watch?
Know your full price
Medication, clinician review and shipping are included. See your total before you buy.
Same price at every included dose
Your plan price stays the same across its included prescribed doses. Choose 1, 3, 6 or 12 months.
Support beyond your prescription
Ongoing doctor messaging, health coaching and patient community access are included with your plan.
Choose your medication and the plan length that works for you.
Buy semaglutide
Compounded
Tirzepatide
Any prescribed dose up to 15 mg/week
Prescription & clinician review included
Shipping included
$1,548 due today
Treatment requires a prescription and clinician approval. If treatment is declined, your payment is refunded. Compounded medications are not FDA-approved.
Investigation Overview
Aspire Health is unusually honest about the regulatory status of what it sells and unusually opaque about what it costs and what happens if you want out. Our research (August 8, 2026) found good disclosure on one axis and three consumer-unfriendly terms on another.
The Disclosure Is Correct
Aspire states that "Compounded medications are prepared by licensed compounding pharmacies based on a provider's prescription" and acknowledges they are "not FDA-approved in their compounded form." That is accurate and specific, and we credit it. Plenty of competitors describe compounded semaglutide in language designed to blur the distinction from Wegovy.The Clinical Process
Four stages: complete intake, consent and registration; provider review and acceptance; an initial clinical evaluation, synchronous or asynchronous per applicable law; then the provider determines whether treatment is clinically appropriate. "Synchronous or asynchronous per applicable law" means you may or may not speak to anyone, depending on your state's requirements. That is honest phrasing, and it tells you the depth of contact is set by the legal minimum rather than by clinical preference.Three Terms to Understand Before Paying
1. No pricing is published. None. Not the consultation fee, not the medication cost. Third-party financing through Cherry is offered, which tells you the amounts are large enough that people finance them, without telling you what they are. 2. Consultation fees are generally non-refundable. In Aspire's words, they are "generally non-refundable once a consultation, clinical review, asynchronous evaluation, or other provider service has occurred." Read that carefully. An asynchronous evaluation — a provider reading your form — is enough to make the fee non-refundable. You can pay, have your intake reviewed, be declined, and not get the money back. Compare that with Fifty 410, which takes no payment at all until you are approved, or VITAstir, which refunds in full if the physician does not approve. 3. Medications are final sales. No returns once dispensed. That is normal for prescription medication and we would not mark a provider down for it alone — but stacked on top of an unpublished price and a non-refundable evaluation, it means every stage of this transaction is one-way.Availability
Aspire states it is "currently serving multiple states" with "availability varies based on provider licensure and state regulations," referencing a map dated July 2026 without naming states in the material we reviewed.Our Investigation Summary
Our research (August 8, 2026) found Aspire Health offering compounded semaglutide and tirzepatide with correct and specific disclosure — it states these are "not FDA-approved in their compounded form," which many competitors obscure. Its process runs intake, consent and registration; provider review and acceptance; an initial clinical evaluation described as "synchronous or asynchronous per applicable law"; then a clinical appropriateness determination. Three terms weigh against it. No pricing is published anywhere, though third-party financing via Cherry is offered. Consultation fees are "generally non-refundable once a consultation, clinical review, asynchronous evaluation, or other provider service has occurred" — meaning a provider simply reading your intake form is sufficient to forfeit the fee, even if you are declined. And medications are final sales. Individually each is defensible; together they mean every stage of the transaction is one-way with no price visible at the outset. Availability is described only as "multiple states" with a July 2026 map. Best approached only after obtaining the consultation fee, the medication price and the decline policy in writing.
How Aspire Health Works
1
Complete intake, consent and registration
2
A provider reviews and accepts you into the program
3
Undergo an initial clinical evaluation — synchronous or asynchronous depending on your state's law
4
The provider determines whether treatment is clinically appropriate
5
Note that consultation fees become non-refundable once any review or asynchronous evaluation has occurred, including if you are declined
6
Medications are final sales once dispensed
7
Before paying anything, get the consultation fee, the medication price and the decline policy in writing — none is published
What We Found
What's Good
- States correctly and specifically that its compounded medications are not FDA-approved in compounded form
- Describes its clinical evaluation process honestly, including that it may be asynchronous where law permits
- Provider review and clinical appropriateness determination before prescribing
- Medication prepared by licensed compounding pharmacies on a provider's prescription
- Third-party financing available through Cherry for those who need it
- Discloses its refund limitations upfront rather than burying them
Watch Out For
- No pricing published anywhere — neither consultation nor medication cost
- Consultation fees are generally non-refundable once any review or asynchronous evaluation has occurred, including if you are declined
- Medications are final sales with no returns
- Clinical evaluation may be asynchronous, set by the legal minimum rather than clinical need
- States served are not named, only described as 'multiple states'
- Compounding pharmacies are not individually named
- Compounded medications are not FDA-approved, and 2026 restrictions on GLP-1 compounding apply
Pricing Breakdown
Starting Price
Not published — no consultation or medication pricing is disclosed
Medication Cost
Not published. Compounded semaglutide and tirzepatide are offered
Subscription Fees
Not published. Third-party financing through Cherry is available, which implies material sums without disclosing them
Hidden Fees
Consultation fees are generally non-refundable once a consultation, clinical review or asynchronous evaluation has occurred — including if you are then declined. Medications are final sales. Supplements follow third-party vendor policies
Safety & Medical Oversight
Aspire Health dispenses compounded semaglutide and tirzepatide and states correctly that these are "not FDA-approved in their compounded form," prepared by licensed compounding pharmacies on a provider's prescription. Compounded drugs are not reviewed by the FDA for safety, effectiveness or manufacturing quality before reaching patients. Since the tirzepatide shortage resolved in October 2024 and semaglutide in early 2025, lawful 503A compounding requires a documented clinical reason specific to the individual patient. The clinical evaluation is described as "synchronous or asynchronous per applicable law," meaning whether you actually speak to a clinician depends on your state's minimum requirement rather than clinical judgment — if your medical history is complex, request a synchronous consultation rather than accepting an asynchronous review. The compounding pharmacies are not individually named; ask which one fills your prescription. GLP-1 receptor agonists are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Customer Support
The support picture is difficult to assess because the commercial terms are unpublished. What is stated is restrictive: consultation fees are generally non-refundable once any provider service including an asynchronous evaluation has occurred, and medications are final sales. Third-party financing through Cherry is offered. Availability is described as multiple states with variation by provider licensure. We found no substantial independent review record in our checks, which combined with the absence of published pricing leaves a prospective patient with very little to evaluate before committing.
Key Features
Compounded Semaglutide & Tirzepatide
States Medications Are Not FDA-Approved
Provider Review & Acceptance
Synchronous or Asynchronous Evaluation
Cherry Financing Available
Licensed Compounding Pharmacies
Multiple States (Not Named)
Best For
Few readers as things stand. If you pursue it, get the consultation fee, the medication cost and what happens if you are declined in writing before paying anything
Customer Reviews & Complaints
We looked for independent customer feedback on Aspire Health as of August 8, 2026 and found little substantial third-party record.
What we verified directly from the company's own pages: compounded semaglutide and tirzepatide with an explicit statement that they are not FDA-approved in compounded form; the four-stage process ending in a clinical appropriateness determination; the description of evaluation as synchronous or asynchronous per applicable law; Cherry financing; the non-refundable consultation fee policy; and medications being final sales.
The term most likely to produce disputes is the non-refundable consultation fee triggered by an asynchronous evaluation. A patient who pays, submits an intake, has it read, and is declined has spent money and received nothing. Several competitors handle this better — Fifty 410 takes no payment until approval, and VITAstir refunds fully if the physician declines.
What we could not verify: any pricing, the states served, or which pharmacies compound the medication.
Is Aspire Health Legit?
"Is Aspire Health legit?" Our assessment as of August 8, 2026.
Official Verification: Aspire Health operates a functioning telehealth service with provider review, clinical appropriateness determination and fulfilment through licensed compounding pharmacies. We found no indication of fraud or misrepresentation.
Its disclosure is genuinely good on the medical question. Stating that compounded medications are "not FDA-approved in their compounded form" is accurate, specific, and better than the vague phrasing much of this industry uses. It also discloses its refund limitations rather than hiding them, which is a form of honesty even when the terms themselves are restrictive.
The commercial structure is where the rating comes from. No published price, a consultation fee that becomes non-refundable the moment a provider reads your form, and medication sold as final sale means the customer carries risk at every stage while never seeing a number before committing.
Red Flags Check:
- ✓ Accurate, specific FDA disclosure on compounded medications
- ✓ Provider review and clinical appropriateness determination
- ✓ Refund limitations disclosed rather than concealed
- ✓ Financing option available
- ⚠ No pricing published at all
- ⚠ Consultation fees non-refundable after an asynchronous evaluation, even if declined
- ⚠ Medications final sale
- ⚠ Evaluation depth set by legal minimum, not clinical need
- ⚠ States and pharmacies not named
The Bottom Line: Honest about the medicine, opaque about the money, and structured so that you carry the risk at every step. There are providers in this category that take no payment until they have approved you. Unless something here specifically suits you, start with one of those. If you do proceed, get the consultation fee, the medication price and the decline policy in writing first. As always, consult your personal physician before starting any new medication program.
Our Verdict: Caution Advised
Aspire Health has a 6/10 site score. We've identified some concerns that potential customers should be aware of. We recommend reviewing our top picks before proceeding.
Visit Aspire HealthAspire Health
Caution Advised
6/10
Not published — obtain the consultation fee, medication price and decline policy in writing before paying. Cherry financing available
Prescription treatment requires clinician review
Investigation Summary
Overall Rank#130 of 226
Rating6/10
StatusCaution Advised
PricingNot published — obtain the consultation fee, medication price and decline policy in writing before paying. Cherry financing available
Share Your Experience
Help others by sharing your experience with Aspire Health
Want to compare options?
View All 226 ProvidersUser Reviews
Rating Summary
No ratings yet
Rate your experience
Click a star to rate and add a review
Questions & Discussions
226 Providers Reviewed
Explore Other Reviews
Compare with other GLP-1 weight loss providers we've investigated
Our Top Picks
Promotional placement: CoreAge Rx is featured #1 and SuperHealthy Rx #2. Placements and site scores are not independent clinical ratings or patient review averages. We may earn compensation from referral links. How our rankings work.
#1 RecommendedExcellent
#2 RecommendedExcellent
#3 RecommendedGreat
Mochi Health
8.8
Affordable GLP-1 Access Starting at $99/Month with No Long-Term Commitment
More Provider Reviews
CoreAge Rx
9.9
SuperHealthy Rx
9.7
Mochi Health
8.8
Remedy Meds
8.3
Caution Advised
Ready to Get Started with Aspire Health?
Review our findings above and make an informed decision about Aspire Health.
Enter to Win a $1,788 CoreAge Rx Gift Card
Enter for a chance to use it toward eligible CoreAge Rx products and services.
The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.